Type 1 diabetes: UK approves first drug for delaying onset
Kate Bowie , 2025-08-15 14:55:00 The UK’s medicines regulator has approved the first immunotherapy to be licensed to delay the progression of type 1 diabetes in patients who are in the early stages of the disease. The Medicines and Healthcare Products Regulatory Agency (MHRA) said teplizumab (Tzield), manufactured by Sanofi, can be given to adults…